AMGEN Inc
NASDAQ: AMGN
$283.66
-$12.27 (-4.1%)
Real Time Data Delayed 15 Min.
AMGN Articles
Coherus Biosciences saw its shares crater on Monday after the company announced that it received a complete response letter from the FDA regarding its biologics license application for a...
Published:
Last Updated:
The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Boeing, PepsiCo and other top companies scheduled to report their quarterly results on Wednesday.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
Published:
Last Updated:
The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of the ACA fell through, the health care rally is called into question.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include American Express, Amgen, Encana, Gilead Science and Tesla.
Published:
Last Updated:
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.
Published:
Last Updated:
One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is the large cap biotechs.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday include Broadcom, Canadian Solar, Goldman Sachs, TripAdvisor and Wal-Mart.
Published:
Last Updated:
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Published:
Last Updated:
Amgen Inc. (NASDAQ: AMGN) reported its fourth-quarter financial results after the markets closed on Thursday. This biotech giant posted $2.89 in earnings per share (EPS) and $5.97 billion in revenue,...
Published:
Last Updated: